Adaptimmune Therapeutics shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $0 | 4.2k | 0.00 |
| 2023-09-30 | $0 | 4.4k | 0.00 |
| 2023-06-30 | $0 | 4.2k | 0.00 |
| 2023-03-31 | $20k | 19k | 1.04 |
| 2022-12-31 | $144k | 99k | 1.46 |
| 2018-06-30 | $1.9M | 161k | 11.87 |
| 2018-03-31 | $1.3M | 112k | 11.23 |